MTOR and depressive disorder: It has been elucidated that phosphorylation of the mTOR signaling pathway is severely decreased in patients with major depression, while ketamine, an N-methyl-d-aspartate (NMDA) antagonist, has been shown to increase mTOR activity and relieve depression [63].